XWELL, Inc. to Announce Third Quarter 2022 Financial Results on Thursday, November 10

Rhea-AI Summary

XWELL, Inc. (Nasdaq: XWEL) plans to announce its third quarter 2022 financial results on November 10, 2022, after the market closes. Following this announcement, a webcast and conference call will be held at 4:30 PM ET. Investors can participate via a limited-capacity conference call or stream the event live from the Investor Relations section of XWELL's website. The company operates several wellness brands, including XpresCheck, XpresSpa, Treat, and HyperPointe.

Positive

• Upcoming Q3 earnings announcement on November 10, 2022.
• Hosting a conference call for investor engagement post-earnings.

Negative

• None.

Webcast and Conference Call Scheduled for 4:30 PM ET

NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading global health and wellness holding company, today announced that it will release third quarter 2022 financial results on Thursday, November 10, 2022, after the market close. The announcement will be followed by a webcast and conference call at 4:30 p.m. ET.

The Company encourages investors and interested parties to listen via webcast as there is a limited capacity to access the conference call by dialing 1-201-689-8263.

The live and later archived webcast can be accessed from the Investor Relations section of the Company’s website at https://www.xwell.com. Visitors to the website should select the “Investors” tab and navigate to the “Events” link to access the webcast.

About XWELL, Inc.
XWELL, Inc. (Nasdaq: XWEL) is a leading global health and wellness holding company operating four brands: XpresCheck®, XpresSpa®, Treat™ and HyperPointe.

• XpresSpa is a leading airport retailer of wellness services and related products, with 28 locations in 14 airports globally.
• Treat is a travel health and wellness brand and a fully integrated concept blending technology with traditional brick and mortar offerings to provide a holistic approach to physical and mental well-being for travelers, currently located in three airports.
• XpresCheck is a leading provider of COVID-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo, conducting bio-surveillance monitoring in its airport locations to identify new SARS-CoV2 variants of interest and concern as well as other pathogens entering the country from across the world.
• HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry.

Forward-Looking Statements

This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Forward-looking statements relating to expectations about future results or events are based upon information available to XWELL as of today's date and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other Securities and Exchange Commission filings (which reports were filed under the Company’s former name, XpresSpa Group, Inc., prior to its previously announced name change effective October 25, 2022). All subsequent written and oral forward-looking statements concerning XWELL, or other matters and attributable to XWELL or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XWELL does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

Media
Heather Tidwell
MWW
htidwell@mww.com

Investor Relations
Joseph Calabrese
MWW
ir@xwell.com

FAQ

When will XWELL release its Q3 2022 earnings?

XWELL will release its Q3 2022 earnings on November 10, 2022, after market close.

What time is the XWELL conference call scheduled?

The conference call is scheduled for 4:30 PM ET on November 10, 2022.

How can I access the XWELL earnings call?

You can listen to the XWELL earnings call via webcast on the Investor Relations section of their website.

What brands does XWELL operate?

XWELL operates several brands including XpresCheck, XpresSpa, Treat, and HyperPointe.